A carregar...
Exosomal PD-L1: Roles in tumor progression and immunotherapy
The use of immune checkpoint therapies targeting programmed death-1 (PD-1) and its ligand (PD-L1) continue to show limited, durable success in clinical cases, despite widespread application. While some patients achieve complete responses and disease remission, others are completely resistant to the...
Na minha lista:
| Publicado no: | Trends Cancer |
|---|---|
| Main Authors: | , |
| Formato: | Artigo |
| Idioma: | Inglês |
| Publicado em: |
2020
|
| Assuntos: | |
| Acesso em linha: | https://ncbi.nlm.nih.gov/pmc/articles/PMC7330176/ https://ncbi.nlm.nih.gov/pubmed/32610067 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1016/j.trecan.2020.03.002 |
| Tags: |
Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!
|